Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Mind the gap: Expediting gender parity in MD-PhD admissions
Temperance R. Rowell, … , Donna S. Neuberg, Loren D. Walensky
Temperance R. Rowell, … , Donna S. Neuberg, Loren D. Walensky
Published February 27, 2020
Citation Information: JCI Insight. 2020;5(4):e136037. https://doi.org/10.1172/jci.insight.136037.
View: Text | PDF
Perspective

Mind the gap: Expediting gender parity in MD-PhD admissions

  • Text
  • PDF
Abstract

The 2018 National MD-PhD Program Outcomes Study highlighted the critical need to increase MD-PhD trainee diversity and close the gender gap in MD-PhD enrollment. This Association of American Medical Colleges imperative prompted us to evaluate trends in female matriculation from our institutional MD-PhD program compared with national data. Based on a 10-year review of Harvard/MIT Medical Scientist Training Program admissions, we observed a sharp and sustained increase in female matriculants for the past 5 years that is well above the national average. We report our experience with achieving gender parity among matriculants of our MD-PhD program, identify the specific stage of the admissions process where the gender balance acutely shifted, and attribute the increase in female matriculation to concrete administrative changes that were put into place just prior to the observed gender balance shift. These changes included increasing the number of faculty participants in application screening and awardee selection and establishing gender balance among faculty decision makers. We believe that adopting basic administrative practices geared toward increasing the diversity of perspectives among admissions faculty has the potential to expedite gender parity of MD-PhD matriculants nationwide and could eventually help achieve gender balance in the national physician-scientist workforce.

Authors

Temperance R. Rowell, Robert A. Redd, Donna S. Neuberg, Loren D. Walensky

×

Figure 3

Accelerated female matriculation in the Harvard/MIT MSTP derives from an increased percentage of female MD-PhD interviews, offers, and acceptances since AY2015–2016.

Options: View larger image (or click on image) Download as PowerPoint
Accelerated female matriculation in the Harvard/MIT MSTP derives from an...
The percentage of female applicants was plotted at each stage of the Harvard/MIT MSTP admissions process over time from AY2010–2011 to AY2019–2020, with 3-year rolling means fit using linear regressions for the preadministrative (AY2010–2011 to AY2014–2015) and postadministrative (AY2015–2016 to AY2019–2020) change period. Actual data, crimson circles and solid connected line. Smoothed and fit data, white circles and dashed line. (A) The percentage of female applicants to the Harvard/MIT MSTP. (B) The percentage of female applicants after screening by Harvard Medical School (MD Screened-In). (C) The percentage of female applicants after the Harvard/MIT MSTP screen for granting interviews (MD-PhD Screened-In). (D) The percentage of female applicants who received an offer from the Harvard/MIT MSTP (MD-PhD Offered). (E) The percentage of female applicants who accepted an MD-PhD offer (MD-PhD Accepted). (F) The percentage of female applicants who matriculated into the Harvard/MIT MSTP. n = 609–714 per year (Total Applicants, both genders); n = 145–209 per year (MD Screened-In applicants, both genders); n = 66–91 per year (MD-PhD Screened-In applicants, both genders); n = 15–19 per year (MD-PhD Offered applicants, both genders); n = 10–16 per year (MD-PhD Accepted applicants, both genders); n = 11–15 per year (MD-PhD Matriculated applicants, both genders).

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts